| 000 | 01624 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515162557.0 | ||
| 264 | 0 | _c20100511 | |
| 008 | 201005s 0 0 chi d | ||
| 022 | _a1003-0603 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSu, Lei | |
| 245 | 0 | 0 |
_a[Clinical effects of ulinastatin and thymosin alpha1 on immune-modulation in septic patients]. _h[electronic resource] |
| 260 |
_bZhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue _cMar 2009 |
||
| 300 |
_a147-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycoproteins _xtherapeutic use |
| 650 | 0 | 4 |
_aHLA-DR Antigens _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-10 _xblood |
| 650 | 0 | 4 |
_aInterleukin-4 _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 | _aLipopolysaccharide Receptors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSepsis _xdrug therapy |
| 650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _ximmunology |
| 650 | 0 | 4 | _aThymalfasin |
| 650 | 0 | 4 |
_aThymosin _xanalogs & derivatives |
| 700 | 1 | _aMeng, Fan-su | |
| 700 | 1 | _aTang, You-qing | |
| 700 | 1 | _aWen, Qiang | |
| 700 | 1 | _aLiu, Yun-song | |
| 700 | 1 | _aTang, Li-qun | |
| 700 | 1 | _aDuan, Peng-kai | |
| 700 | 1 | _aLuo, Rui-jun | |
| 773 | 0 |
_tZhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue _gvol. 21 _gno. 3 _gp. 147-50 |
|
| 999 |
_c18718163 _d18718163 |
||